Medical simulation market to hit $1.9B by 2017

Over the past decade, the healthcare medical simulation industry has experienced significant growth due to the focus on patient safety and technological advancements—with more growth to come.

The market, which primarily includes simulation products and services that are used to train students and clinicians, is forecast to reach $1.9 billion by 2017, according a report from global market research firm MarketsandMarkets. The 2012 market value was estimated at $790.1 million.

Major end-users of simulation products include academics, hospitals and military, with academics accounting for the largest market share in 2012. Geographically, North America and Europe are the top markets for the medical simulation industry but the Asian market—in particular China and India—are expected to be major players, according to the report.

The market is mainly driven by increasing healthcare costs, rising demand for minimally invasive treatments and increasing consolidation of manufacturers. The high cost of simulators, economic slowdown in the developed region and limited availability of funds, however, may inhibit its growth to some degree, reported MarketsandMarkets.

To learn more about the report, go here.

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.